JPS6234933A - Radiation-resistant polyolefin composition - Google Patents
Radiation-resistant polyolefin compositionInfo
- Publication number
- JPS6234933A JPS6234933A JP60172935A JP17293585A JPS6234933A JP S6234933 A JPS6234933 A JP S6234933A JP 60172935 A JP60172935 A JP 60172935A JP 17293585 A JP17293585 A JP 17293585A JP S6234933 A JPS6234933 A JP S6234933A
- Authority
- JP
- Japan
- Prior art keywords
- polyolefin
- weight
- radiation
- hindered amine
- aromatic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Apparatus For Disinfection Or Sterilisation (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
Description
【発明の詳細な説明】 〔産業上の利用分野〕 好適なポリオレフィン組成物に関スル。[Detailed description of the invention] [Industrial application field] Regarding suitable polyolefin compositions.
従来、医療用器具等の殺菌方法としては、エチレンオキ
サイドガスによる方法やスチームによる高温殺菌等が日
常的に使用されてきたが、製品表面へのエチレンオキサ
イドガスの吸着残留問題や細部の殺菌が不完全となって
しまう等の問題により、γ線等の放射線照射による方法
が普及しつつある。Traditionally, methods using ethylene oxide gas and high-temperature sterilization using steam have been routinely used to sterilize medical instruments, etc., but there are problems with ethylene oxide gas adsorption remaining on the product surface and the inability to sterilize small details. Due to problems such as complete irradiation, methods using radiation such as gamma rays are becoming popular.
しかしながら、ポリオレフィン製品に放射線を照射する
と樹脂が劣化し、分子量の低下、衝撃強度の低下、着色
、溶出物の増加等種々の問題点が生じて実用に耐えない
。この問題の解決のため様々な改善方法が試みられ、例
えば、ヒンダードアミンを添加する方法(特開昭55−
19199号公報)、特定の亜リン酸エステルを添加す
る方法(特開昭57−179234号公報)等が提案さ
れている。しかし、これらの方法ではある程度の改良は
みられるものの実用製品としての要求を満たすには不十
分であった。However, when polyolefin products are irradiated with radiation, the resin deteriorates, resulting in various problems such as a decrease in molecular weight, a decrease in impact strength, coloring, and an increase in eluates, making it impractical for practical use. Various improvement methods have been tried to solve this problem, such as the method of adding hindered amine (Japanese Patent Application Laid-Open No. 55-1999).
19199), a method of adding a specific phosphite (Japanese Patent Application Laid-open No. 179234/1983), etc. have been proposed. However, although these methods showed some improvement, they were insufficient to meet the requirements for practical products.
本発明は、かかる問題点を解決すること、即ち、実用性
十分な耐放射線性のポリオレフィン製品を提供すること
を目的として鋭意検討の結果、ポリオレフィンに特定の
化合物を併用配合することによって放射線劣化を極めて
有効に抑制して秀れてバランスのとれた物性を有するポ
リオレフィン組成物が得られることを見い出して為され
たものである。The present invention was developed as a result of intensive studies aimed at solving these problems, that is, providing a radiation-resistant polyolefin product with sufficient practicality. This was accomplished based on the discovery that polyolefin compositions having excellent and well-balanced physical properties can be obtained by suppressing the effects extremely effectively.
即ち、本発明は、[ポリオレフィン100i!量部に下
記の(A)〜(q各成分を配合したことを特徴とすル耐
放射線性ポリオレフィン組成物
(A) ヘテロサイクリツク型ヒンダードアミン系安定
剤0.01〜1重量部
(Bl 芳香族面リン酸エステル系または芳香族フオ
スフオナイト系酸化防止剤0.01〜1重量部
(C) 架橋助剤0.01〜2重量部」である。That is, the present invention provides polyolefin 100i! Radiation-resistant polyolefin composition (A) 0.01 to 1 part by weight of heterocyclic hindered amine stabilizer (Bl aromatic 0.01 to 1 part by weight of surface phosphate ester or aromatic phosphonite antioxidant (C) 0.01 to 2 parts by weight of crosslinking aid.
本発明の組成物は、放射線照射による着色、分子量低下
(MFR増加)、耐熱老化性の低下等が抑制され、物性
保持性に秀れているので放射線殺菌される理化学用およ
び医療用器具、放射線殺菌される食品または薬品用容器
のほか、放射線または原子力施設で使用される器具、備
品、着衣、敷き物、履き物等に好適であり、また、病院
や食品工場等で用いる不織布や繊維等で作られるフィル
ター、膜、衣服等もおる。The composition of the present invention suppresses discoloration, molecular weight decrease (MFR increase), decrease in heat aging resistance, etc. due to radiation irradiation, and has excellent physical property retention, so it can be used for physical and chemical and medical instruments that are sterilized by radiation. Suitable for food or drug containers to be sterilized, as well as instruments, supplies, clothing, rugs, footwear, etc. used in radiation or nuclear facilities, and also for containers made of non-woven fabrics or fibers used in hospitals, food factories, etc. There are also filters, membranes, clothing, etc.
本発明で用いるポリオレフィンは、エチレン、プロピレ
ン、ブテン、4−メチルペンテン、ヘキセン等のα−オ
レフィンの単独または共重合体、若しくは、これらα−
オレフィンと生重量未満の他のビニル単量体(酢酸ビニ
ル、アクリル酸、無水マレイン酸、スチレン等)とのラ
ンダム、ブロックないしはグラフト共重合体、その外、
これら単独または共重合体の酸化、塩素化等の処理物等
のいわゆるオレフィン重合体を用いることができるO
具体的には、例えば、低・中・高密度ポリエチレン、エ
チレンやブテン或いはヘキセン等ヲ共重合させた線状低
密度ポリエチレン、ポリプロピレン(単独重合体)、グ
ロビレンーエチレンブロックまたはランダム共重合体、
プロピレン−エチレン−ブテン共重合体、ポリブテン、
ポリ−4−メチルペンテン、エチレン−ブテン共重合体
等が好適であり、特に好ましいポリオレフィンは、ポリ
プロピレン、プロピレン−エチレンランダムまたはブロ
ック共重合体、プロピレン−エチレン−ブテン共重合体
である。これらは併用しても差し支えない。The polyolefin used in the present invention is a homopolymer or a copolymer of α-olefins such as ethylene, propylene, butene, 4-methylpentene, hexene, or these α-olefins.
Random, block or graft copolymers of olefins and less than fresh weight of other vinyl monomers (vinyl acetate, acrylic acid, maleic anhydride, styrene, etc.);
So-called olefin polymers such as oxidized, chlorinated, etc. treated products of these alone or copolymers can be used. Specifically, for example, low, medium, and high density polyethylene, ethylene, butene, hexene, etc. Polymerized linear low density polyethylene, polypropylene (homopolymer), globylene-ethylene block or random copolymer,
Propylene-ethylene-butene copolymer, polybutene,
Poly-4-methylpentene, ethylene-butene copolymer, etc. are suitable, and particularly preferred polyolefins are polypropylene, propylene-ethylene random or block copolymer, and propylene-ethylene-butene copolymer. These may be used in combination.
本発明で用いるヘテロサイクリック型ヒンダードアミン
系安定剤の具体例としては、例えば、(以下余白)
6一
などが挙げられる。上記式中Mはメチル基を表す。Specific examples of the heterocyclic hindered amine stabilizer used in the present invention include (hereinafter referred to as blank space) 61. In the above formula, M represents a methyl group.
これらのうち分子量が500以上のもの、即ち、上記式
(2)〜(A)、(7)および(9)〜(イ)の化合物
等がブリードの点で好ましい。Among these, those having a molecular weight of 500 or more, ie, the compounds of the above formulas (2) to (A), (7) and (9) to (a), are preferred from the viewpoint of bleeding.
この化合物の配合量は、ポリオレフィン100重量部に
対して0.01〜1重量部、好ましくは0.03〜0.
5重量部である。配合量が少ないと効果がなく、多いと
ブリード、着色、不経済等の問題が生じる。The compounding amount of this compound is 0.01 to 1 part by weight, preferably 0.03 to 0.1 part by weight, per 100 parts by weight of polyolefin.
5 parts by weight. If the amount is too small, there will be no effect, and if the amount is too large, problems such as bleeding, coloring, and uneconomical effects will occur.
また、本発明で用いる芳香族亜リン酸エステル系または
芳香族フオスフォナイト系酸化防止剤の具体例としては
、例えば、
(以下余白)
H3tBu
などが挙げられる。上記式中tBuはt−ブチル基を表
す。Further, specific examples of the aromatic phosphite-based or aromatic phosphonite-based antioxidant used in the present invention include H3tBu (hereinafter referred to as a blank). In the above formula, tBu represents a t-butyl group.
これらのうち特に、式(2)、a時、(ト)および(ホ
)の化合物が好ましい。Among these, compounds of formula (2), a, (g) and (e) are particularly preferred.
この化合物の配合量は、ポリオレフィン100重量部に
対して0.01〜1重量部、好ましくは0.03〜0.
5重量部である。との範囲をはずれると前記のヒンダー
ドアミン系安定剤と同様な問題が生じて好ましくない。The compounding amount of this compound is 0.01 to 1 part by weight, preferably 0.03 to 0.1 part by weight, per 100 parts by weight of polyolefin.
5 parts by weight. If it deviates from this range, problems similar to those of the hindered amine stabilizers described above will occur, which is not preferable.
さらに、本発明で用いる架橋助剤の具体例は、例えば、
トリアリルイソシアヌレート、トリアリルシアヌレート
、エチレングリコールジメチルアクリレート、ジアリル
フタレート、トリメチレンプロパントリメタアクリレー
ト、ジビニルベンゼン、ペンタエリトリット−テトラア
クリル酸エステルなどが挙げられる。配合量はポリオレ
フィン100重量部に対して帆01〜2重量部、好まし
くは0.03〜0.7重量部である。少ないと効果がな
く、多いと却って品質が悪化する。Further, specific examples of the crosslinking aid used in the present invention include, for example,
Examples include triallyl isocyanurate, triallyl cyanurate, ethylene glycol dimethyl acrylate, diallyl phthalate, trimethylenepropane trimethacrylate, divinylbenzene, pentaerythritol-tetraacrylic acid ester, and the like. The blending amount is 01 to 2 parts by weight, preferably 0.03 to 0.7 parts by weight, per 100 parts by weight of the polyolefin. If it is too little, it will not be effective, and if it is too much, the quality will deteriorate.
本発明の組成物には、これらの必須成分の外に、フェノ
ール系、イオウ系、上記以外のリン系等の安定剤、金属
石ケン類、核剤、顔料、滑剤、帯電防止剤、アンチブロ
ッキング剤、紫外線吸収剤、光安定剤、分散剤、架橋剤
、分子量調整剤、充填剤等の付加的成分を本発明の効果
を著しく損なわない範囲で配合することもできる。In addition to these essential components, the composition of the present invention also contains stabilizers such as phenol-based, sulfur-based, and phosphorus-based stabilizers other than those listed above, metal soaps, nucleating agents, pigments, lubricants, antistatic agents, and anti-blocking agents. Additional components such as a UV absorber, a light stabilizer, a dispersant, a crosslinking agent, a molecular weight regulator, a filler, etc. may be added within a range that does not significantly impair the effects of the present invention.
本発明の組成物は、通常の樹脂の混線方法または成形方
法にて製造される。例えば、粉状またはペレット状ポリ
オレフィンに各必須成分および所望の付加的成分を配合
し、ヘンシェルミキサー等で混合したのち、−軸ないし
二軸等の押出機で溶融混合してペレット状組成物となす
。配合成分は、ポリオレフィンに混線途中で添加されて
もよく、また、マスターバッチ方式で添加されてもよい
。The composition of the present invention is manufactured by a conventional resin cross-wiring method or molding method. For example, powdered or pelleted polyolefin is blended with each essential component and desired additional components, mixed in a Henschel mixer, etc., and then melt-mixed in a -screw or twin-screw extruder to form a pelletized composition. . The compounding components may be added to the polyolefin during mixing, or may be added by a masterbatch method.
得られたペレットを、射出成形、押出成形、中空成形、
圧空成形、フィルム成形、熱圧成形、紡糸等の各種成形
に供し、さらには必要に応じて二次加工を加えて成形体
製品を得る。The obtained pellets are subjected to injection molding, extrusion molding, blow molding,
The molded product is subjected to various molding processes such as air pressure molding, film molding, hot pressure molding, and spinning, and is further subjected to secondary processing as necessary to obtain a molded product.
かかる製品に照射される放射線は、α、β、γ、X線等
がよく知られており、特にγ線が透過力および線量の均
一性の点で便利で為る。照射線量は、一般に、医療用器
具殺菌では1.5〜5Mrad、食品や飼料殺菌では2
Mrad程度の範囲で選ばれる。The radiation irradiated to such products is well known to include α, β, γ, X-rays, etc., and γ-rays are particularly convenient in terms of penetrating power and uniformity of dose. The irradiation dose is generally 1.5 to 5 Mrad for medical instrument sterilization, and 2 Mrad for food and feed sterilization.
Selected within a range of about Mrad.
MFRがsy/1o分、エチレン含景4重量係のプロピ
レン−エチレンランダム共重合体100重量部に第1表
記載の各成分およびステアリン酸カルシウム0.05重
i[を配合してヘンシェルミキサーでブレンドした後、
30瓢径−軸押出機で溶融混練してペレットとした。こ
のペレットを射出成形機(240℃)で成形して120
XBOx26鱈の試片を作製し、これに2.4〜2.6
Mradのコバルト60線源によるγ線を照射した。100 parts by weight of a propylene-ethylene random copolymer with an MFR of sy/1o and an ethylene content of 4 parts by weight were blended with each component listed in Table 1 and 0.05 weight i of calcium stearate using a Henschel mixer. rear,
The mixture was melt-kneaded using a 30-diameter screw extruder to form pellets. This pellet was molded with an injection molding machine (240°C) and
Prepare a specimen of XBOx26 cod, and add 2.4 to 2.6
Gamma irradiation was performed with a Mrad cobalt-60 source.
照射後の試片について、MFR,カラーマシンによる色
相(b値)、140℃オープン中での脆化時間および8
0℃オープンで1週間熱処理した試片を指で折り曲げた
ときの割れやクラック発生状況を評価した。その結果は
第1表に示す通りである。Regarding the specimen after irradiation, MFR, hue (b value) by color machine, embrittlement time in open at 140°C, and 8
The specimens were heat-treated at 0°C for one week and evaluated for cracks and cracks when bent with fingers. The results are shown in Table 1.
なお、第1表のなかで、(A)成分および(ハ)成分は
上記説明中での各番号式に該当する化合物を示し、また
、(C)成分の’rAICはトリアリルイソシアヌレー
ト、PTAEはペンタエリトリット−テトラアクリル酸
エステルを示す。その他成分のRItoloはテトラキ
ス(2,5−ジーtブチルー4−ヒドロキシフェニルプ
ロピオネート)メタンヲ示す0
(以下余白)In Table 1, components (A) and (C) indicate compounds corresponding to each number formula in the above explanation, and 'rAIC of component (C) is triallylisocyanurate, PTAE. indicates pentaerythritol-tetraacrylic acid ester. Other ingredients, RItolo, indicate tetrakis(2,5-di-t-butyl-4-hydroxyphenylpropionate)methane.
Claims (1)
成分を配合したことを特徴とする耐放射線性ポリオレフ
ィン組成物。 (A)ヘテロサイクリツク型ヒンダードアミン系安定剤
0.01〜1重量部 (B)芳香族亜リン酸エステル系または芳香族フオスフ
オナイト系酸化防止剤0.01〜1重量部 (C)架橋助剤0.01〜2重量部[Scope of Claims] A radiation-resistant polyolefin composition characterized in that each of the following components (A) to (C) is blended with 100 parts by weight of polyolefin. (A) Heterocyclic hindered amine stabilizer 0.01 to 1 part by weight (B) Aromatic phosphite or aromatic phosphonite antioxidant 0.01 to 1 part by weight (C) Crosslinking aid 0 .01-2 parts by weight
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60172935A JPS6234933A (en) | 1985-08-06 | 1985-08-06 | Radiation-resistant polyolefin composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60172935A JPS6234933A (en) | 1985-08-06 | 1985-08-06 | Radiation-resistant polyolefin composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS6234933A true JPS6234933A (en) | 1987-02-14 |
Family
ID=15951077
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP60172935A Pending JPS6234933A (en) | 1985-08-06 | 1985-08-06 | Radiation-resistant polyolefin composition |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6234933A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH026547A (en) * | 1988-02-29 | 1990-01-10 | Phillips Petroleum Co | Polymer composition reduced in corrosion tendency |
| JPH02153953A (en) * | 1988-12-06 | 1990-06-13 | Tonen Sekiyukagaku Kk | Radiation-resistant polyolefin composition |
| FR2705679A1 (en) * | 1993-05-24 | 1994-12-02 | Sandoz Sa | Novel stabilizing compositions of polymeric materials based on phosphonites or phosphites and a stabilizer against hydrolysis. |
| JP2003000695A (en) * | 2001-06-21 | 2003-01-07 | Bmg:Kk | Radiation sterilizable medical materials and their uses |
| WO2005026262A1 (en) * | 2002-07-03 | 2005-03-24 | Daicel-Degussa Ltd. | Resin compositions, composites made by using the same, and process for production thereof |
-
1985
- 1985-08-06 JP JP60172935A patent/JPS6234933A/en active Pending
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH026547A (en) * | 1988-02-29 | 1990-01-10 | Phillips Petroleum Co | Polymer composition reduced in corrosion tendency |
| JPH02153953A (en) * | 1988-12-06 | 1990-06-13 | Tonen Sekiyukagaku Kk | Radiation-resistant polyolefin composition |
| FR2705679A1 (en) * | 1993-05-24 | 1994-12-02 | Sandoz Sa | Novel stabilizing compositions of polymeric materials based on phosphonites or phosphites and a stabilizer against hydrolysis. |
| JP2003000695A (en) * | 2001-06-21 | 2003-01-07 | Bmg:Kk | Radiation sterilizable medical materials and their uses |
| WO2005026262A1 (en) * | 2002-07-03 | 2005-03-24 | Daicel-Degussa Ltd. | Resin compositions, composites made by using the same, and process for production thereof |
| KR100996991B1 (en) | 2002-07-03 | 2010-11-25 | 다이셀 에보닉 가부시키가이샤 | Resin composition, composite using the same and method for producing same |
| US7989540B2 (en) | 2002-07-03 | 2011-08-02 | Daicel-Evonik Ltd. | Resin composition and composite using the composition and production process thereof |
| US8029910B2 (en) | 2002-07-03 | 2011-10-04 | Daicel-Evonik Ltd. | Resin composition and composite using the composition and production process thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4569736A (en) | Medical instruments made from a polyolefin composition which has been sterilized with gamma irradiation | |
| US5376716A (en) | Radiation resistant polypropylene resins | |
| NO176803B (en) | Radiation sterilizable propylene polymer blend and its use | |
| JPH06322193A (en) | Radiation resistant polypropylene resin composition | |
| US6060561A (en) | Use of thermoplastic elastomers for improving the stability of polyolefins to ionizing radiation | |
| JP2006508213A (en) | Irradiated and oxidized olefin polymer coupling agent | |
| JPS6234933A (en) | Radiation-resistant polyolefin composition | |
| JPH0551023B2 (en) | ||
| US10570279B2 (en) | Polypropylene resin composition and molded body for medical use, which uses same | |
| JP2528443B2 (en) | Low-dissolution drug solution, infusion, blood transfusion device | |
| JPH0674348B2 (en) | Weather resistant resin composition | |
| JP2019031609A (en) | Polypropylene resin composition and medical molded article using the same | |
| JPS6361038A (en) | Radiation-resistant polyolefin composition | |
| EP1692241A2 (en) | Radiation resistant polypropylene useful in medical applications | |
| JP2770201B2 (en) | Radiation resistant polypropylene composition | |
| WO2004113438A1 (en) | Process for making visbroken olefins polymers | |
| JPS6333444A (en) | Radiation-resistant polyolefin composition | |
| JPH02215848A (en) | Radiation-resistant polypropylene resin composition | |
| JPH07309978A (en) | Polyolefin resin composition containing inorganic filler | |
| JP3339033B2 (en) | Polypropylene composition | |
| JPS60215036A (en) | Radiation-resistant polyolefin | |
| JPH04142354A (en) | Radiation-resistant polyolefin packaging material | |
| JPH07188472A (en) | Radiation resistant polyolefin composition | |
| JPH04311747A (en) | Polypropylene-based resin composition | |
| JPH09118793A (en) | Polypropylene composition |